Molecules that are able to inhibit the binding between NGF and the TrkA receptor as analgesics with prolonged effect

Details for Australian Patent Application No. 2012201465 (hide)

Owner Abbott Research B.V

Inventors Cattaneo, Antonio; Martinelli, Sara; Ugolini, Gabriele; Pavone, Flaminia

Agent Spruson & Ferguson

Pub. Number AU-A-2012201465

Parent 2006256387

Filing date 12 March 2012

Wipo publication date 5 April 2012

International Classifications

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

29 March 2012 Complete Application Filed

5 April 2012 Application Open to Public Inspection

  Published as AU-A-2012201465

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012201466-Code Transformation

2012201464-A Process for the Preparation of Beer Having High Alcohol Strength with Winey Beery Character